Unravelling the triglyceride story

Media formats available:

Ready to Claim Your Credits?

You have attempts to pass this post-test. Take your time and review carefully before submitting.

Good luck!

Integrating EPA-based therapy in the management of residual CV risk
Integrating EPA-based therapy in the management of residual CV risk
Tackling residual risk beyond LDL-c therapy: The emerging role of EPA & triglycerides
Integrating EPA-based therapy in the management of residual CV risk
- Prof. Ph. Gabriel Steg, MD
What is the evidence of EPA-based therapy for CV prevention?
What is the evidence of EPA-based therapy for CV prevention?
Tackling residual risk beyond LDL-c therapy: The emerging role of EPA & triglycerides
What is the evidence of EPA-based therapy for CV prevention?
- Prof. Lale Tokgözoğlu, MD